aDepartment of Molecular Diagnostics, Holy Cross Cancer Center
bDivision of Medical Biology, Institute of Biology, Jan Kochanowski University, Kielce
cDepartment of Genetics, Wroclaw Medical University, Wroclaw
dDepartment of Ophthalmology and Ocular Oncology, Faculty of Medicine, Jagiellonian University Medical College, Krakow
eDepartment of Pathomorphology, University Hospital in Krakow, Krakow
fDivision of Clinical Pathology, Department of Clinical and Experimental Pathology, Wroclaw Medical University
gDepartment of Pathology and Clinical Cytology, Jan Mikulicz-Radecki University Hospital, Wroclaw, Poland
hDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Received 8 September 2022 Accepted 28 November 2022
*Piotr Donizy and Mai P. Hoang contributed equally to the writing of this article.
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.melanomaresearch.com.
Correspondence to Piotr Donizy, MD, Department of Clinical and Experimental Pathology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland, Tel: +48 71 734 3955; e-mail: [email protected]